Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia

Hanine El Haddad; Anne Marie Chaftari; Ray Hachem; Majd Micheal; Ying Jiang; Ammar Yousif; Sammy Raad; Mary Jordan; Patrick Chaftari; Issam Raad

doi:10.1038/s41598-018-19616-3

Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia

Hanine El Haddad, Anne Marie Chaftari, Ray Hachem, Majd Micheal, Ying Jiang, Ammar Yousif, Sammy Raad, Mary Jordan, Patrick Chaftari, Issam Raad

Infectious Diseases, Infection Control, and Employee Health

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

In this analysis, we identified febrile cancer patients with documented infections or neutropenia, whose procalcitonin levels are low at baseline or decrease on antibiotics. These patients had similar outcomes in terms of mortality and relapse of infection regardless of the duration of antimicrobial therapy (less or more than 7 days).

Original language	English (US)
Article number	1099
Journal	Scientific reports
Volume	8
Issue number	1
DOIs	https://doi.org/10.1038/s41598-018-19616-3
State	Published - Dec 1 2018

ASJC Scopus subject areas

General

Access to Document

10.1038/s41598-018-19616-3

Cite this

@article{c5c415a76f5d45148fd3533668b49ba8,

title = "Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia",

abstract = "In this analysis, we identified febrile cancer patients with documented infections or neutropenia, whose procalcitonin levels are low at baseline or decrease on antibiotics. These patients had similar outcomes in terms of mortality and relapse of infection regardless of the duration of antimicrobial therapy (less or more than 7 days).",

author = "Haddad, {Hanine El} and Chaftari, {Anne Marie} and Ray Hachem and Majd Micheal and Ying Jiang and Ammar Yousif and Sammy Raad and Mary Jordan and Patrick Chaftari and Issam Raad",

note = "Publisher Copyright: {\textcopyright} 2018 The Author(s).",

year = "2018",

month = dec,

day = "1",

doi = "10.1038/s41598-018-19616-3",

language = "English (US)",

volume = "8",

journal = "Scientific reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia

AU - Haddad, Hanine El

AU - Chaftari, Anne Marie

AU - Hachem, Ray

AU - Micheal, Majd

AU - Jiang, Ying

AU - Yousif, Ammar

AU - Raad, Sammy

AU - Jordan, Mary

AU - Chaftari, Patrick

AU - Raad, Issam

PY - 2018/12/1

Y1 - 2018/12/1

N2 - In this analysis, we identified febrile cancer patients with documented infections or neutropenia, whose procalcitonin levels are low at baseline or decrease on antibiotics. These patients had similar outcomes in terms of mortality and relapse of infection regardless of the duration of antimicrobial therapy (less or more than 7 days).

AB - In this analysis, we identified febrile cancer patients with documented infections or neutropenia, whose procalcitonin levels are low at baseline or decrease on antibiotics. These patients had similar outcomes in terms of mortality and relapse of infection regardless of the duration of antimicrobial therapy (less or more than 7 days).

UR - http://www.scopus.com/inward/record.url?scp=85040768621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040768621&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-19616-3

DO - 10.1038/s41598-018-19616-3

M3 - Article

C2 - 29348438

AN - SCOPUS:85040768621

SN - 2045-2322

VL - 8

JO - Scientific reports

JF - Scientific reports

IS - 1

M1 - 1099

ER -

Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this